Skip to content

Clinical trials

Completed Multiple Sclerosis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Status: Completed Country / region: Australia Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20066
20075
20085
20094
20103
20113
20122
20133
20142
20152
20163
20182
20191
20202
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen10
Novartis Pharmaceuticals8
Genzyme, a Sanofi Company4
Novartis4
GlaxoSmithKline3
Merck KGaA, Darmstadt, Germany3
Bayer2
Sanofi2
Actelion1
Astellas Pharma Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis47
Multiple Sclerosis, Relapsing-Remitting10
Recurrence7
Demyelinating Diseases1
Disease Progression1
Fatigue1
Multiple Sclerosis, Chronic Progressive1
Neuroinflammatory Diseases1
Optic Nerve Diseases1
Optic Neuritis1

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.